Amisulpride Augmentation in Schizophrenia Patients with Poor Response to Olanzapine: A 4-week, Randomized, Rater-Blind, Controlled, Pilot Study

OBJECTIVE: The purpose of this study was to compare the efficacy and tolerability of continued olanzapine (OLA) versus amisulpride (AMI) augmentation in schizophrenic patients with poor response to OLA monotherapy. METHODS: The present 4-week, randomized, rater-blinded study included 25 patients wit...

Descripción completa

Detalles Bibliográficos
Autores principales: Woo, Young Sup, Park, Sung-Yong, Yoon, Bo-Hyun, Choi, Won-Seok, Wang, Sheng-Min, Bahk, Won-Myong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean College of Neuropsychopharmacology 2022
Materias:
Brief Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9329105/
https://www.ncbi.nlm.nih.gov/pubmed/35879041
http://dx.doi.org/10.9758/cpn.2022.20.3.567

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9329105/
https://www.ncbi.nlm.nih.gov/pubmed/35879041
http://dx.doi.org/10.9758/cpn.2022.20.3.567

Ejemplares similares